Wellgistics Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	36.74	18.13	-	-
Cost of Revenue	33.77	16.36	-	-
Gross Profit	2.97	1.77	-	-
Selling, General & Admin	42.59	6.8	2.88	0.02
Operating Expenses	45.31	7.91	2.88	0.02
Operating Income	-42.34	-6.15	-2.88	-0.02
Interest Expense	-3.11	-0.83	-0.02	-
Other Non Operating Income (Expenses)	0.14	0.12	-	-
Pretax Income	-45.3	-6.86	-2.9	-0.02
Net Income	-45.3	-6.86	-2.9	-0.02
Net Income to Common	-45.3	-6.86	-2.9	-0.02
Shares Outstanding (Basic)	52	47	45	-
Shares Outstanding (Diluted)	52	47	45	-
Shares Change (YoY)	-	5.66%	-	-
EPS (Basic)	-0.87	-0.15	-0.06	-
EPS (Diluted)	-0.87	-0.15	-0.06	-
Gross Margin	8.08%	9.75%	-	-
Operating Margin	-115.25%	-33.90%	-	-
Profit Margin	-123.31%	-37.82%	-	-
EBITDA	-39.63	-5.03	-	-
EBITDA Margin	-107.88%	-27.75%	-	-
D&A For EBITDA	2.71	1.11	-	-
EBIT	-42.34	-6.15	-2.88	-0.02
EBIT Margin	-115.25%	-33.90%	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q